...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: BETonMACE Placebo Estimate

KK2 - Sorry I don't know how they came up with the .6% plaque regression number. I only know it was the primary goal that we fell short of. I had heard that if more patients were compliant in taking all of the drugs prescribed during the ASSURE trial it likely would have been a very different outcome, as in passing that trials primary goal. Oh well it's water under the bridge now. I think if I was a patient in this trial and had been reading this board I wouldn't miss a single dose and would hope to heck I was in dosed category given all the good things this drug seems to do.

tada

Share
New Message
Please login to post a reply